These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7515913)

  • 21. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
    Asokan R; Hua J; Young KA; Gould HJ; Hannan JP; Kraus DM; Szakonyi G; Grundy GJ; Chen XS; Crow MK; Holers VM
    J Immunol; 2006 Jul; 177(1):383-94. PubMed ID: 16785534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23.
    Schulz O; Sutton BJ; Beavil RL; Shi J; Sewell HF; Gould HJ; Laing P; Shakib F
    Eur J Immunol; 1997 Mar; 27(3):584-8. PubMed ID: 9079796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E.
    Shi J; Ghirlando R; Beavil RL; Beavil AJ; Keown MB; Young RJ; Owens RJ; Sutton BJ; Gould HJ
    Biochemistry; 1997 Feb; 36(8):2112-22. PubMed ID: 9047310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
    Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
    Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21.
    Gill MB; Roecklein-Canfield J; Sage DR; Zambela-Soediono M; Longtine N; Uknis M; Fingeroth JD
    J Cell Sci; 2004 Jun; 117(Pt 13):2709-20. PubMed ID: 15138285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection of human B lymphoma cells by Mycoplasma fermentans induces interaction of its elongation factor with the intracytoplasmic domain of Epstein-Barr virus receptor (gp140, EBV/C3dR, CR2, CD21).
    Balbo M; Barel M; Lottin-Divoux S; Jean D; Frade R
    FEMS Microbiol Lett; 2005 Aug; 249(2):359-66. PubMed ID: 16054780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
    Debnath I; Roundy KM; Weis JJ; Weis JH
    Mol Immunol; 2007 Mar; 44(9):2388-99. PubMed ID: 17140663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes.
    Debnath I; Roundy KM; Weis JJ; Weis JH
    J Immunol; 2007 Jun; 178(11):7139-50. PubMed ID: 17513763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.
    Kovacs JM; Hannan JP; Eisenmesser EZ; Holers VM
    J Biol Chem; 2010 Aug; 285(35):27251-27258. PubMed ID: 20558730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes.
    Pochon S; Graber P; Yeager M; Jansen K; Bernard AR; Aubry JP; Bonnefoy JY
    J Exp Med; 1992 Aug; 176(2):389-97. PubMed ID: 1386872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
    Guthridge JM; Rakstang JK; Young KA; Hinshelwood J; Aslam M; Robertson A; Gipson MG; Sarrias MR; Moore WT; Meagher M; Karp D; Lambris JD; Perkins SJ; Holers VM
    Biochemistry; 2001 May; 40(20):5931-41. PubMed ID: 11352728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis.
    Bonnefoy JY; Henchoz S; Hardie D; Holder MJ; Gordon J
    Eur J Immunol; 1993 Apr; 23(4):969-72. PubMed ID: 8458382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of a chimeric form of CD23 that is oligomeric and blocks IgE binding to the Fc epsilonRI.
    Kelly AE; Chen BH; Woodward EC; Conrad DH
    J Immunol; 1998 Dec; 161(12):6696-704. PubMed ID: 9862699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors.
    Lacy J; Roth G; Shieh B
    J Immunol; 1994 Dec; 153(12):5537-48. PubMed ID: 7989755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H; Brenner C; Jacobi S; Gorka J; Carel JC; Kinoshita T; Holers VM
    J Biol Chem; 1991 Jul; 266(19):12173-9. PubMed ID: 1712014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
    Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
    Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling of the lectin-homology domains of the human and murine low-affinity Fc epsilon receptor (Fc epsilon RII/CD23).
    Padlan EA; Helm BA
    Receptor; 1993; 3(4):325-41. PubMed ID: 8142907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD23-mediated IgE transport across human intestinal epithelium: inhibition by blocking sites of translation or binding.
    Tu Y; Salim S; Bourgeois J; Di Leo V; Irvine EJ; Marshall JK; Perdue MH
    Gastroenterology; 2005 Sep; 129(3):928-40. PubMed ID: 16143132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).
    Hannan JP
    Curr Protein Pept Sci; 2016; 17(5):463-87. PubMed ID: 26916158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.